Alyeska Investment Group
TRAW icon

Alyeska Investment Group’s Traws Pharma TRAW Stock Holding History

Alyeska Investment Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,630
Closed -$77.9K – 744
2025
Q2 		$77.9K Hold
52,630
– – ﹤0.01% 542
2025
Q1 		$121K Sell
52,630
-64,084
-55% -$333K ﹤0.01% 490
2024
Q4 		$1.04M Buy
+116,714
New +$650K ﹤0.01% 494
2021
Q4 		– Sell
-10,000
Closed -$958K – 739
2021
Q3 		$958K Buy
+10,000
New +$1.29M 0.01% 611
2021
Q2 		– Sell
-1,775
Closed -$665K – 863
2021
Q1 		$665K Buy
+1,775
New +$670K 0.01% 642
2015
Q2 		– Sell
-2
Closed -$221K – 594
2015
Q1 		$221K Sell
2
-1
-33% -$164K ﹤0.01% 485
2014
Q4 		$487K Buy
+3
New +$734K 0.01% 443

Other funds holding TRAW

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return